Aanjaneya Lifecare has received an approval for overseas expansion whereby it has decided to open subsidiary companies and offices in Singapore and UAE. The board at its meeting held on January 09, 2012 has approved for the same.
Further, the board has also authorized the managing director of the company, to negotiate the terms and conditions for acquisition of 100% assets and business of Apex Drugs & Intermediates.
Aanjaneya Lifecare is a leading research based integrated pharmaceutical company with established research, manufacturing and marketing capabilities. It is R&D focused, has a multi product portfolio with state of the art manufacturing facilities, and is set to become a marketing conglomerate across the globe.
